Finding 1075015 (2021-003)

Material Weakness
Requirement
ABL
Questioned Costs
-
Year
2021
Accepted
2024-09-26

AI Summary

  • Core Issue: The Association failed to review and approve 26 invoices and 6 timesheets, lacking necessary internal controls for federal award compliance.
  • Impacted Requirements: Non-compliance with 2 CFR 200.303(a) increases the risk of claiming ineligible expenditures under the Provider Relief Fund.
  • Recommended Follow-Up: Enhance internal controls to ensure all financial documents are reviewed and approved, including a secondary review for final reports submitted to HHS.

Finding Text

Department of Health and Human Services Federal Assistance Listing/CFDA #93.498 COVID-19 Provider Relief Fund and American Rescue Plan Rural Distribution Criteria 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition The Association had 26 invoices identified as eligible that were not reviewed and approved. The Associations had 6 timesheets that were not reviewed and approved. In addition, the Association’s final expenditure listing, lost revenue calculation identified as eligible and claimed under the Provider Relief Fund program, and special report submitted to the Department of Health and Human Services for Period 1 did not have evidence of being reviewed and approved by a separate individual outside of the preparer. Cause The Association did not have an adequate internal control policy in place to ensure review and approval over specifically identified invoices and timesheets, the final expenditure listing, the lost revenue calculation, or preparation of HHS Period 1 reporting were documented. Effect The lack of adequate policies governing the review and approval of invoices, timesheets, expenditure listings, lost revenue calculation and the HHS Period 1 report increases the risk that employees participating in the federal award administration may not be able to detect and correct noncompliance in a timely manner. Without a secondary review and approval, there is a possibility that ineligible expenditures may be claimed under the program. Context Detail testing was completed over $777,856 of the expenses along with the calculation for lost revenue for activities allowed and unallowable and allowable cost/cost principles. A nonstatistical sample of 40 expenditures (29 nonpayroll and 11 payroll) were selected for detailed testing, 26 invoices did not have evidence of being reviewed and approved and 6 timesheets didn’t have evidence of being reviewed. The overall expense listings and lost revenue worksheet did not have evidence of a review by someone other than the preparer (i.e., population of two). The Report submitted to HHS also did not have a documented secondary review and approval (i.e., population of one). Recommendation We recommend the Association enhance internal controls policies to ensure all invoices are reviewed and approved to ensure all expenses claimed under the federal program are necessary, correct and meet the requirements of the federal program. We also recommend the Association implement a control process which includes a secondary review and approval of the final expenditure listing and lost revenue calculation used to claim the allowable costs under the federal program and that there is documented evidence of the review and approval. In addition, the Report submitted to HHS should have a secondary review and approval that is documented.Views of Responsible Officials and Planned Corrective Actions Management agrees with the finding, has prepared an assessment of the root causes of this material weakness, and has developed a corrective action plan. Indication of Repeat Finding This is not a repeat finding in the current year.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 498569 2021-002
    Material Weakness
  • 498570 2021-002
    Material Weakness
  • 498571 2021-002
    Material Weakness
  • 498572 2021-002
    Material Weakness
  • 498573 2021-003
    Material Weakness
  • 498574 2021-004
    Material Weakness
  • 1075011 2021-002
    Material Weakness
  • 1075012 2021-002
    Material Weakness
  • 1075013 2021-002
    Material Weakness
  • 1075014 2021-002
    Material Weakness
  • 1075016 2021-004
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $796,522
93.155 Rural Health Research Centers $75,567
93.889 National Bioterrorism Hospital Preparedness Program $16,890
93.461 Hrsa Covid-19 Claims Reimbursement for the Uninsured Program and the Covid-19 Coverage Assistance Fund $8,072